<?xml version="1.0" encoding="UTF-8"?>
<p>Previous studies show that the disease burden of liver cancer is increasing and that it is not equally distributed throughout the population.
 <xref rid="R9" ref-type="bibr">9</xref> Incidence rates are elevated in East and South-East Asia, Africa and Melanesia, with nearly three-quarters of new liver cancer cases occurring in regions of low or medium development.
 <xref rid="R3" ref-type="bibr">3</xref> In China, the reported averages for the annual incidence and mortality of liver cancer between 2003 and 2007 were approximately 26.68/100 000 and 25.03/100 000, respectively.
 <xref rid="R10" ref-type="bibr">10</xref> In 2015, China accounted for over half of the worldwide liver cancer incident cases (446 100 cases) and deaths (422 100 cases).
 <xref rid="R11" ref-type="bibr">11</xref> Historically, liver cancer has been the most prevalent malignancy in China.
</p>
